Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Cancer|August 15, 1996
Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumorsL H Wexler, T F DeLaney, M Tsokos, et al.
Cancer Research|October 1, 1985
Pediatric phase I trial and pharmacokinetic study of tiazofurin (NSC 286193)F M Balis, B J Lange, R J Packer, et al.
Antimicrobial Agents and Chemotherapy|December 3, 1998
Serum and cerebrospinal fluid pharmacokinetics of intravenous and oral lamivudine in human immunodeficiency virus-infected childrenB U Mueller, L L Lewis, G J Yuen, et al.
Cancer Chemotherapy and Pharmacology|March 5, 2004
Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101P C Adamson, S M Blaney, B C Widemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicinL H Wexler, M P Andrich, D Venzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group StudyS M Blaney, M N Needle, A Gillespie, et al.
Cancer Chemotherapy and Pharmacology|November 17, 2001
Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumorsK E Warren, M C Patel, A A Aikin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2010
Pharmacokinetically guided phase 1 trial of the IGF-1 receptor antagonist RG1507 in children with recurrent or refractory solid tumorsR Bagatell, C E Herzog, T M Trippett, et al.
Cancer Chemotherapy and Pharmacology|January 13, 2006
Phase II trial of intravenous lobradimil and carboplatin in childhood brain tumors: a report from the Children's Oncology GroupK Warren, R Jakacki, B Widemann, et al.
Blood|November 10, 1998
Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch studyF M Balis, J S Holcenberg, D G Poplack, et al.
Pageof 15